NasdaqGS:LEGNBiotechs
How Legend Biotech’s Boardroom Shake-Up and New Audit Chair Will Impact Legend Biotech (LEGN) Investors
Legend Biotech recently expanded its board by appointing veteran finance executive Gareth Kung as a Class II director and new audit committee chair, while adding GenScript chairman Robin Meng and announcing the resignations of Li Zhu and Yau Wai Man Philip, which the company said were not due to disagreements.
The addition of a seasoned cross-border capital markets specialist to lead the audit committee, alongside deeper representation from major shareholder GenScript, marks a meaningful...